PureCycle Technologies Valuation
Is PCT * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PCT * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PCT * (MX$238.21) is trading below our estimate of fair value (MX$1080.63)
Significantly Below Fair Value: PCT * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PCT *?
Key metric: As PCT * is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is PCT *'s PB Ratio? | |
|---|---|
| PB Ratio | 8.6x |
| Book | US$241.42m |
| Market Cap | US$2.07b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | -20.8x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does PCT *'s PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.9x | ||
ORBIA * Orbia Advance Corporation. de | 0.6x | 18.4% | Mex$33.2b |
ALPEK A ALPEK. de | 1x | 106.2% | Mex$29.8b |
CYDSASA A Cydsa. de | 0.7x | 20.9% | Mex$9.0b |
GCC * GCC. de | 1.5x | -1.6% | Mex$56.9b |
PCT * PureCycle Technologies | 8.6x | 60.5% | Mex$2.1b |
Price-To-Book vs Peers: PCT * is expensive based on its Price-To-Book Ratio (8.6x) compared to the peer average (0.9x).
Price to Book Ratio vs Industry
How does PCT *'s PB Ratio compare vs other companies in the South American Chemicals Industry?
| 0 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Book vs Industry: PCT * is expensive based on its Price-To-Book Ratio (8.6x) compared to the Global Chemicals industry average (1.6x).
Price to Book Ratio vs Fair Ratio
What is PCT *'s PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 8.6x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate PCT *'s Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$238.21 | Mex$268.30 +12.6% | 16.1% | Mex$307.21 | Mex$194.57 | n/a | 5 |
| Nov ’25 | Mex$292.93 | Mex$174.96 -40.3% | 34.0% | Mex$278.35 | Mex$119.29 | n/a | 5 |
| Oct ’25 | n/a | Mex$175.56 0% | 40.3% | Mex$305.33 | Mex$114.50 | n/a | 5 |
| Sep ’25 | n/a | Mex$175.56 0% | 40.3% | Mex$305.33 | Mex$114.50 | n/a | 5 |
| Aug ’25 | n/a | Mex$155.96 0% | 54.6% | Mex$297.95 | Mex$74.49 | n/a | 4 |
| Jul ’25 | n/a | Mex$146.93 0% | 51.0% | Mex$290.24 | Mex$72.56 | n/a | 5 |
| Jun ’25 | n/a | Mex$130.38 0% | 54.0% | Mex$267.45 | Mex$66.86 | n/a | 5 |
| May ’25 | n/a | Mex$130.38 0% | 54.0% | Mex$267.45 | Mex$66.86 | n/a | 5 |
| Apr ’25 | n/a | Mex$131.12 0% | 54.0% | Mex$268.97 | Mex$67.24 | n/a | 5 |
| Mar ’25 | n/a | Mex$119.24 0% | 66.4% | Mex$272.54 | Mex$51.10 | n/a | 5 |
| Feb ’25 | n/a | Mex$119.24 0% | 66.4% | Mex$272.54 | Mex$51.10 | n/a | 5 |
| Jan ’25 | n/a | Mex$129.73 0% | 58.0% | Mex$273.11 | Mex$51.21 | n/a | 5 |
| Dec ’24 | n/a | Mex$174.72 0% | 38.1% | Mex$282.38 | Mex$105.89 | n/a | 5 |
| Nov ’24 | n/a | Mex$254.22 0% | 14.0% | Mex$306.76 | Mex$204.51 | Mex$292.93 | 6 |
| Oct ’24 | n/a | Mex$254.22 0% | 14.0% | Mex$306.76 | Mex$204.51 | n/a | 6 |
| Sep ’24 | n/a | Mex$254.22 0% | 14.0% | Mex$306.76 | Mex$204.51 | n/a | 6 |
| Aug ’24 | n/a | Mex$227.36 0% | 11.3% | Mex$267.81 | Mex$200.85 | n/a | 6 |
| Jul ’24 | n/a | Mex$221.13 0% | 15.6% | Mex$273.91 | Mex$171.20 | n/a | 6 |
| Jun ’24 | n/a | Mex$222.61 0% | 20.1% | Mex$286.86 | Mex$161.36 | n/a | 6 |
| May ’24 | n/a | Mex$222.61 0% | 20.1% | Mex$286.86 | Mex$161.36 | n/a | 6 |
| Apr ’24 | n/a | Mex$221.61 0% | 17.8% | Mex$284.11 | Mex$170.47 | n/a | 5 |
| Mar ’24 | n/a | Mex$248.11 0% | 12.1% | Mex$277.73 | Mex$203.67 | n/a | 5 |
| Feb ’24 | Mex$201.00 | Mex$263.26 +31.0% | 11.1% | Mex$292.51 | Mex$214.51 | n/a | 6 |
| Jan ’24 | n/a | Mex$263.26 0% | 11.1% | Mex$292.51 | Mex$214.51 | n/a | 6 |
| Dec ’23 | n/a | Mex$263.26 0% | 11.1% | Mex$292.51 | Mex$214.51 | n/a | 6 |
| Nov ’23 | n/a | Mex$327.99 0% | 12.1% | Mex$401.62 | Mex$281.13 | n/a | 6 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
CRH
UK£32.3b
Provides building materials solutions in Ireland and internationally.
CRH N
UK£960.44
7D
0%
1Y
48.5%
Celanese
US$8.2b
A chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally.
CE *
US$1,495.25
7D
n/a
1Y
n/a
Companhia Siderúrgica Nacional
R$14.7b
Operates as an integrated steel producer in Brazil and Latin America.
SID N
R$37.95
7D
0%
1Y
-32.2%